Register
Register
Register

BioLinker

Startup / Scaleup

biolinker.tech/Cotia, Brazil

About

BioLinker is a São Paulo‑based synthetic biology powerhouse, engineering next‑generation proteins via AI-driven platforms. As the first Latin American company to provide cell‑free systems for complex protein expression, BioLinker serves Fortune 500 clients and specializes in hard‑to‑express proteins for pharma, agriculture, diagnostics, and industrial biotech. Website

Their proprietary Sol platform offers modular, scalable protein engineering—blending in‑silico design, cell‑free and cell‑based systems, directed evolution, and purification pipelines.

In 2022, BioLinker gained recognition for developing a rapid SARS‑CoV‑2 self‑test—producing all reagents locally in São Paulo, supported by FAPESP’s PIPE program, with 15‑minute home results across all variants agencia.fapesp.br.

The company has also been featured at scientific article at PubMed as recent publication Antigen

Awards & recognition:

  • Top 500 DeepTech Startup (Hello Tomorrow)

  • Top 3 Biotech Startup in Brazil (100 Open Startups)

  • Sebrae “Startup of the Future”

  • Top 40 at Wolves Summit

  • USP Alumni Award for Innovation & Entrepreneurship .

Social media

Services

Commercialisation and partnershipsPatent licensingTechnology transfer

Advanced manufacturing technologies

Cellular manufacturing or group layout

Industry

Biotechnology

Industry 4.0

Artificial intelligence (AI)

Manufacturing

Manufacture of basic pharmaceutical products and pharmaceutical preparations

Representatives

Oliveira Mona

CEO

BioLinker

Marketplace (3)

  • Service

    Protein on demand

    Custom proteins on demand—designed, expressed, and delivered using AI and synthetic biology for research, diagnostics, or industry.

    • Research & Development
    Author

    Oliveira Mona

    CEO at BioLinker

    Cotia, Brazil

  • Product

    InvitroLinker

    InvitroLinker boosts swine sperm viability by up to 70%—a protein-based additive for more efficient artificial insemination.

    • Buyer
    • Commercial agent
    • Re-Seller/Wholesaler
    • Biotech, Pharma and Cosmetics
    Author

    Oliveira Mona

    CEO at BioLinker

    Cotia, Brazil

  • Investment

    Seed Investment

    BioLinker seeks seed investment to scale its synbio platform and launch high-impact biotech solutions like InvitroLinker.

    • Seed and Development
    • Biotech, Pharma and Cosmetics
    Author

    Oliveira Mona

    CEO at BioLinker

    Cotia, Brazil